Developments in the internal dosimetry of radiopharmaceuticals.
about
A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.Assessment of MIRD data for internal dosimetry using the GATE Monte Carlo code.
P2860
Developments in the internal dosimetry of radiopharmaceuticals.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Developments in the internal dosimetry of radiopharmaceuticals.
@ast
Developments in the internal dosimetry of radiopharmaceuticals.
@en
type
label
Developments in the internal dosimetry of radiopharmaceuticals.
@ast
Developments in the internal dosimetry of radiopharmaceuticals.
@en
prefLabel
Developments in the internal dosimetry of radiopharmaceuticals.
@ast
Developments in the internal dosimetry of radiopharmaceuticals.
@en
P1476
Developments in the internal dosimetry of radiopharmaceuticals.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.RPD.A006306
P577
2003-01-01T00:00:00Z